These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 11488072)
1. WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms. Goldstein NS; Bassi D; Uzieblo A Am J Clin Pathol; 2001 Aug; 116(2):246-52. PubMed ID: 11488072 [TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores. Goldstein NS Am J Clin Pathol; 2002 Mar; 117(3):471-7. PubMed ID: 11888088 [TBL] [Abstract][Full Text] [Related]
3. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions. Zhu W; Michael CW Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661 [TBL] [Abstract][Full Text] [Related]
4. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases. Vang R; Gown AM; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM Am J Surg Pathol; 2006 Sep; 30(9):1130-9. PubMed ID: 16931958 [TBL] [Abstract][Full Text] [Related]
5. Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies. Goldstein NS; Thomas M Am J Clin Pathol; 2001 Sep; 116(3):319-25. PubMed ID: 11554157 [TBL] [Abstract][Full Text] [Related]
6. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Berezowski K; Stastny JF; Kornstein MJ Mod Pathol; 1996 Apr; 9(4):426-9. PubMed ID: 8729984 [TBL] [Abstract][Full Text] [Related]
7. Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology. Han L; Pansare V; Al-Abbadi M; Husain M; Feng J Diagn Cytopathol; 2010 May; 38(5):333-6. PubMed ID: 19856421 [TBL] [Abstract][Full Text] [Related]
8. Necrosis in 84 ovarian carcinomas: a morphologic study of primary versus metastatic colonic carcinoma with a selective immunohistochemical analysis of cytokeratin subtypes and carcinoembryonic antigen. DeCostanzo DC; Elias JM; Chumas JC Int J Gynecol Pathol; 1997 Jul; 16(3):245-9. PubMed ID: 9421090 [TBL] [Abstract][Full Text] [Related]
9. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold. Goldstein NS; Bassi D Am J Clin Pathol; 2001 May; 115(5):695-702. PubMed ID: 11345833 [TBL] [Abstract][Full Text] [Related]
10. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273 [TBL] [Abstract][Full Text] [Related]
11. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors. Cathro HP; Stoler MH Hum Pathol; 2005 Feb; 36(2):195-201. PubMed ID: 15754297 [TBL] [Abstract][Full Text] [Related]
12. WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas. Goldstein NS; Uzieblo A Am J Clin Pathol; 2002 Apr; 117(4):541-5. PubMed ID: 11939727 [TBL] [Abstract][Full Text] [Related]
13. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis? Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Yoshikawa K; Sato Y; Aoyama H; Hayashi T; Kushima R Hum Pathol; 2008 May; 39(5):666-71. PubMed ID: 18339419 [TBL] [Abstract][Full Text] [Related]
14. Ovarian metastases of pancreaticobiliary tract adenocarcinomas: analysis of 35 cases, with emphasis on the ability of metastases to simulate primary ovarian mucinous tumors. Meriden Z; Yemelyanova AV; Vang R; Ronnett BM Am J Surg Pathol; 2011 Feb; 35(2):276-88. PubMed ID: 21263249 [TBL] [Abstract][Full Text] [Related]
15. Expression of cytokeratins 7 and 20 in ovarian neoplasia. Cathro HP; Stoler MH Am J Clin Pathol; 2002 Jun; 117(6):944-51. PubMed ID: 12047147 [TBL] [Abstract][Full Text] [Related]
16. Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases. Ormsby AH; Haskell R; Jones D; Goldblum JR Mod Pathol; 2000 Jan; 13(1):46-51. PubMed ID: 10658909 [TBL] [Abstract][Full Text] [Related]
17. Immunological reactivity of mucinous and serous ovarian adenocarcinomas. Harłozińska-Szmyrka A; Slesak B; Richter R; Rabczyński J; Cisło M Cancer Detect Prev; 1986; 9(3-4):347-58. PubMed ID: 3017557 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521 [TBL] [Abstract][Full Text] [Related]
19. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors. Tot T Cancer; 1999 Jan; 85(1):171-7. PubMed ID: 9921990 [TBL] [Abstract][Full Text] [Related]